Jason (Feng) Ma

Washington, DC
888-860-5678 x712 (telephone)
888-706-1173 (fax)
Jason (Feng) Ma has extensive experience in food and drug law, intellectual property law, business law as well as China law. Jason has advised numerous pharmaceutical, medical device, food and cosmetics companies on food and drug regulatory matters in China and in the U.S. He has advised numerous companies in a variety of industries for IP matters in China and in the U.S. He has also assisted small and medium-sized businesses with general corporate needs, such as formation and start-up, daily business operations, employment matters, negotiations and development of contracts, immigration matters, purchases and sales of shares and assets and conflict resolution.
Before starting his legal career in 1992, Jason Ma practiced as a medical doctor for four years in a city hospital in Guangzhou. He was formerly a partner of a Chinese law firm in Guangzhou and a senior attorney of Covington & Burling LLP (Beijing and Washington DC).
Representative Cases:
Advised a leading multi-national pharmaceutical company on regulatory requirements for drug promotion.
Advised a leading multi-national pharmaceutical company on regulatory requirements for drug advertisement.
Advised a leading multi-national device company on labeling requirements for medical devices.
Advised a leading multi-national device company on legal requirements relating to clinical trials.
Advised a leading multi-national pharmaceutical company on regulatory requirements for storage of drugs.
Advised a large European pharmaceutical manufacturer on drug registration, the process of gaining marketing approval and the use of trademarks.
Advised clients on trademark application procedures from the initial filing through obtaining the certificate of registration.
Advised clients on trademark opposition actions and acted on behalf of clients in contentious proceedings.
Advised clients on the availability of patent protection prior to filing in China.
Evaluated office actions and provided advice on the response to office actions.
Represented clients in administrative proceedings for domain names.
Represented a U.S. multi-national company in a lawsuit for trademark infringement before the Xianshan District Court of Guilin City of Guangxi, China.
Represented a French publisher before a court in Guangzhou, China and sought damages for copyright infringement.
Represented a Fortune 500 company before Beijing No. 2 Intermediate People’s Court in a lawsuit for a domain name dispute.
Advised clients on administrative actions for the protection of copyrights, trademarks or patents in China, including arranging and supervising investigations against infringers and organizing raid actions.
Advised clients on criminal penalties for intellectual property infringing activities in China.
Advised clients on customs and border protection of intellectual property rights.
Advised clients on intellectual property due diligence in the acquisition of businesses.
Advised clients on immigration matters, including nonimmigrant (H-1B, L-1, etc.) and immigrant visa matters (EB1, EB2, EB5, etc.).
Assisted a Chinese company in acquiring assets of a U.S. entity.
Assisted a Chinese company in acquiring shares of a U.S. company.
Selected Publications and Speaking Engagement:
Speaker, “Regulations of Drugs and Medical Devices” (Panel Discussion), Sino-American Pharmaceutical Professionals Association, Washington, D.C. (Sep. 2016)
Speaker, “Law Firm Operation and Management, the U.S. and China”, Washington, D.C. Chinese Legal Association, Washington, D.C. (Jun. 2016)
Speaker, “China Patent Litigation from a Comparative Perspective”, University of Pennsylvania Law School, Philadelphia, PA (Feb. 2015)
Co-author, “Chinese Regulation of Off-label Use of Drugs”, Food and Drug Law Journal (May 2013)
Co-author, “Regulation of Drug Promotion in China”, Updates (May 2013)
Speaker, “Comparative Transparency: FDA vs. SFDA”, DIA Training Program, Washington DC (Dec. 2012)
Co-author, “China’s New Blacklist: The Impact for Drug and Device Lawbreakers”, Scrip Regulatory Affairs (Sep. 2012)
Author, “Damages for Patent Infringement in China”, Intellectual Property Magazine (Mar. 2012)
Speaker, “Regulation of Drugs in China”, Continuing Legal Education Program, Princeton (Dec. 2011)
Author, “The Position of Compulsory Licensing in China”, Intellectual Property Magazine (Nov. 2011)
Speaker, “Comparison of Clinical Trial Oversight in China and the U.S.”, DIA Annual Meeting China, Beijing, (May 2011)
Speaker, “Comparative Regulatory Systems for Pharmaceuticals”, International Drug Discovery Science and Technology Summit, Beijing (Oct. 2010)
Speaker, “Comparison of IP Litigation: China and US – Bolar Case and Bolar Provision”, Beijing University of Chemical Technology, Beijing (Nov. 2009)
Speaker, “The Third Amendment to the PRC Patent Law and Its Impact on the Pharmaceutical Industry in China”, China Pharmaceutical Regulatory Compliance and Best Practice, Shanghai (Aug. 2009)
Author, “Amending China’s Trademark Law – A Discussion of the Possible Changes to Trademark Law in China”, Trademark World (Jun. 2009)
Honors and Professional Affiliations:
Chambers Partners, Asia-China: Recommended as One of the Leading Attorneys for Life Science (2011–2013)
Panelist, Domain Name Dispute Resolution Center of China International Economic and Trade Arbitration Commission (“CIETAC”) (Since 2004)
Member of China Task Force of Food and Drug Law Institute (“FDLI”) for Conference in Beijing (2013)
Adjunct Professor, Sun Yat-sen University, Law School (2010-2013)
Co-founder and President of Washington DC Chinese Legal Association (2012-2013)
Member of Executive Council of Chinese-American Bio-Pharmaceutical Society (2010-2011)
LLM, University of California, Berkeley School of Law, US
LLM, Sun Yat-Sen University, Law School, China
LLB, Manchester Metropolitan University, UK
Common Professional Examination/Diploma in Legal Studies, Staffordshire University, Law School, UK
MD, Sun Yat-Sen University, Medical School, China
Diploma in Head & Neck Surgery, Sun Yat-Sen University, Medical School, China
Bar Admission
California, District of Columbia, New York, China (inactive), Chinese Patent Bar (inactive)
Mandarin Chinese, Cantonese